Goldman Sachs Upgrades Anacor Pharma To Buy On 'De-Risked' Story By: Benzinga via Benzinga July 21, 2015 at 07:15 AM EDT In a report published Tuesday, Goldman Sachs analyst Gary Nachman upgraded the rating on Anacor Pharmaceuticals Inc (NASDAQ: ANAC) from ... Read More >>